These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22708734)

  • 1. Menin and p53 have non-synergistic effects on tumorigenesis in mice.
    Loffler KA; Mould AW; Waring PM; Hayward NK; Kay GF
    BMC Cancer; 2012 Jun; 12():252. PubMed ID: 22708734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1.
    Bertolino P; Tong WM; Galendo D; Wang ZQ; Zhang CX
    Mol Endocrinol; 2003 Sep; 17(9):1880-92. PubMed ID: 12819299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1.
    Loffler KA; Biondi CA; Gartside M; Waring P; Stark M; Serewko-Auret MM; Muller HK; Hayward NK; Kay GF
    Int J Cancer; 2007 Jan; 120(2):259-67. PubMed ID: 17044021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Cell Death Inhibitor ARC Is Induced in a Tissue-Specific Manner by Deletion of the Tumor Suppressor Gene Men1, but Not Required for Tumor Development and Growth.
    McKimpson WM; Yuan Z; Zheng M; Crabtree JS; Libutti SK; Kitsis RN
    PLoS One; 2015; 10(12):e0145792. PubMed ID: 26709830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconstituted expression of menin in Men1-deficient mouse Leydig tumour cells induces cell cycle arrest and apoptosis.
    Hussein N; Casse H; Fontanière S; Morera AM; Asensio MJ; Bakeli S; Lu JL; Coste I; Di Clemente N; Bertolino P; Zhang CX
    Eur J Cancer; 2007 Jan; 43(2):402-14. PubMed ID: 17184987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of miR-24 in Multiple Endocrine Neoplasia Type 1: A Potential Target for Molecular Therapy.
    Marini F; Brandi ML
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple endocrine neoplasia type 1 knockout mice develop parathyroid, pancreatic, pituitary and adrenal tumours with hypercalcaemia, hypophosphataemia and hypercorticosteronaemia.
    Harding B; Lemos MC; Reed AA; Walls GV; Jeyabalan J; Bowl MR; Tateossian H; Sullivan N; Hough T; Fraser WD; Ansorge O; Cheeseman MT; Thakker RV
    Endocr Relat Cancer; 2009 Dec; 16(4):1313-27. PubMed ID: 19620250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple endocrine neoplasia type 1: a chromatin writer's block.
    Dreijerink KM; Lips CJ; Timmers HT
    J Intern Med; 2009 Jul; 266(1):53-9. PubMed ID: 19522825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue selectivity in multiple endocrine neoplasia type 1-associated tumorigenesis.
    Gracanin A; Dreijerink KM; van der Luijt RB; Lips CJ; Höppener JW
    Cancer Res; 2009 Aug; 69(16):6371-4. PubMed ID: 19654304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence analysis and transcript expression of the MEN1 gene in sporadic pituitary tumours.
    Farrell WE; Simpson DJ; Bicknell J; Magnay JL; Kyrodimou E; Thakker RV; Clayton RN
    Br J Cancer; 1999 Apr; 80(1-2):44-50. PubMed ID: 10389976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple endocrine neoplasia type 1 (MEN1).
    Thakker RV
    Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):355-70. PubMed ID: 20833329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulation of anti-Mullerian hormone/BMP and transforming growth factor-beta pathways in Leydig cell lesions developed in male heterozygous multiple endocrine neoplasia type 1 mutant mice.
    Hussein N; Lu J; Casse H; Fontanière S; Morera AM; Guittot SM; Calender A; Di Clemente N; Zhang CX
    Endocr Relat Cancer; 2008 Mar; 15(1):217-27. PubMed ID: 18310289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.
    Pieterman CR; Conemans EB; Dreijerink KM; de Laat JM; Timmers HT; Vriens MR; Valk GD
    Endocr Relat Cancer; 2014 Jun; 21(3):R121-42. PubMed ID: 24389729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated proliferation and differential global gene expression in pancreatic islets of five-week-old heterozygous Men1 mice: Men1 is a haploinsufficient suppressor.
    Lejonklou MH; Barbu A; Stålberg P; Skogseid B
    Endocrinology; 2012 Jun; 153(6):2588-98. PubMed ID: 22492302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menin molecular interactions: insights into normal functions and tumorigenesis.
    Agarwal SK; Kennedy PA; Scacheri PC; Novotny EA; Hickman AB; Cerrato A; Rice TS; Moore JB; Rao S; Ji Y; Mateo C; Libutti SK; Oliver B; Chandrasekharappa SC; Burns AL; Collins FS; Spiegel AM; Marx SJ
    Horm Metab Res; 2005 Jun; 37(6):369-74. PubMed ID: 16001329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEN1 mutation analysis in Chinese patients with multiple endocrine neoplasia type 1.
    Jiang XH; Lu JL; Cui B; Zhao YJ; Wang WQ; Liu JM; Fang WQ; Cao YN; Ge Y; Zhang CX; Casse H; Li XY; Ning G
    Endocr Relat Cancer; 2007 Dec; 14(4):1073-9. PubMed ID: 18045958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple endocrine neoplasia type 1 associated with a new germline Men1 mutation in a family with atypical tumor phenotype.
    Perakakis N; Flohr F; Kayser G; Thomusch O; Parsons L; Billmann F; von Dobschuetz E; Rondot S; Seufert J; Laubner K
    Hormones (Athens); 2016; 15(1):113-7. PubMed ID: 26732163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SETDB1 Inhibits p53-Mediated Apoptosis and Is Required for Formation of Pancreatic Ductal Adenocarcinomas in Mice.
    Ogawa S; Fukuda A; Matsumoto Y; Hanyu Y; Sono M; Fukunaga Y; Masuda T; Araki O; Nagao M; Yoshikawa T; Goto N; Hiramatsu Y; Tsuda M; Maruno T; Nakanishi Y; Hussein MS; Tsuruyama T; Takaori K; Uemoto S; Seno H
    Gastroenterology; 2020 Aug; 159(2):682-696.e13. PubMed ID: 32360551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased menin expression in sporadic pituitary adenomas.
    Wrocklage C; Gold H; Hackl W; Buchfelder M; Fahlbusch R; Paulus W
    Clin Endocrinol (Oxf); 2002 May; 56(5):589-94. PubMed ID: 12030908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of MEN1 activates DNMT1 implicating DNA hypermethylation as a driver of MEN1 tumorigenesis.
    Yuan Z; Sánchez Claros C; Suzuki M; Maggi EC; Kaner JD; Kinstlinger N; Gorecka J; Quinn TJ; Geha R; Corn A; Pastoriza J; Jing Q; Adem A; Wu H; Alemu G; Du YC; Zheng D; Greally JM; Libutti SK
    Oncotarget; 2016 Mar; 7(11):12633-50. PubMed ID: 26871472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.